Review of Medicare Payments for NovoSeven Coagulation Factor VIIA to Indiana Hemophilia and Thrombosis Center, Inc. From January 1, 2008, Through December 31, 2009
The Indiana Hemophilia and Thrombosis Center, Inc. (the Center) received net Medicare overpayments for NovoSeven dispensations of $435,000 for the period January 1, 2008, through December 31, 2009.
Filed under: Centers for Medicare and Medicaid Services